Why Viking Therapeutics (VKTX) Stock Fell 3.0% on November 12, 2026
-3.02%$27.58November 12, 2026 · S&P 500 -0.35%
The short answer
Viking Therapeutics (VKTX) stock is down 3.0% to $27.58 in the November 12, 2026 session, a move that is much larger than the S&P 500 ETF (SPY), which is down 0.4% in the same session. This decline appears to be specific to VKTX or its industry, rather than reflecting the overall market. Recent headlines, such as "Viking Therapeutics (VKTX) Heads To Two Conferences, Is The Discount To Analyst Targets Warranted?" (Yahoo), could suggest investor caution about the company’s prospects at these conferences, potentially contributing to the stock's drop.
The news behind it
Prediction: $10,000 Invested in Viking Therapeutics Before Its Oral Phase 3 Readouts Could Be Worth This Much by 2028 · The Motley Fool · Nov 13
Before you buy or sell
Get a second opinion on VKTX
The bull case, the bear case and a verdict, with the numbers, in 10 seconds. Free →
Don't miss the next one
Alert me when VKTX moves
Price, RSI and volume alerts by email or push. Free plan →
Full market recap for November 12, 2026 · What's moving VKTX today
Written from that session's quote and the headlines listed above. Educational, not financial advice.